1932

Abstract

Two live oral rotavirus vaccines were approved by the US Food and Drug Administration in 2005 and 2008, following large studies of ∼70,000 each in order to address questions about intussusception triggered by a third earlier vaccine. Both new rotavirus vaccines showed almost identical rates of intussusception in vaccine and placebo recipients. These vaccines have been used extensively in the United States with positive results. Efforts are under way to implement these vaccines in developing countries where the need is greatest.

Keyword(s): diarrheaintussusceptionoralvaccine
Loading

Article metrics loading...

/content/journals/10.1146/annurev-med-121511-093810
2013-01-14
2024-03-28
Loading full text...

Full text loading...

/content/journals/10.1146/annurev-med-121511-093810
Loading
/content/journals/10.1146/annurev-med-121511-093810
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error